top of page

Search Results

Results found for "medicinal chemistry"

Posts (182)

  • Maria’s Travel Blogs: ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025

    Our CSO, Maria, has recently traveled to the US to attend the ACSMEDI-EFMC Medicinal Chemistry Frontiers 2025 , a conference organized by both the EFMC and the ACSMEDI, in an effort to share the most novel medicinal chemistry advancements in both the US and Europe. Another section was dedicated to Chemistry Tools, highlighting their importance. This Chemistry Tools session was more industry focused than those before, and Maria shared the floor

  • 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry. October 5-7, 2022, Verona, Italy

    August 2022 "GPCRs in Medicinal Chemistry Event 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry

  • Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future

    October 2022 "Cannabinoid Receptor 2 (CB2) is a G protein-coupled receptor (GPCR) with considerable, though as yet unrealised, therapeutic potential. Promising preclinical data supports the applicability of CB2 activation in autoimmune and inflammatory diseases, pain, neurodegeneration, and osteoporosis. A diverse pharmacopoeia of cannabinoid ligands is available, which has led to considerable advancements in the understanding of CB2 function and extensive preclinical evaluation. However, until recently, most CB2 ligands were highly lipophilic and as such not optimal for clinical application due to unfavourable physicochemical properties. A number of strategies have been applied to develop CB2 ligands to achieve closer to 'drug-like' properties and a few such compounds have now undergone clinical trial. We review the current state of CB2 ligand development and progress in optimising physicochemical properties, understanding advanced molecular pharmacology such as functional selectivity, and clinical evaluation of CB2-targeting compounds." Read more at the source #DrGPCR #GPCR #IndustryNews

View All

Other Pages (106)

  • Dr. Christel Menet | Dr. GPCR Ecosystem

    Christel Menet "I did my Ph.D. in Manchester UK with Prof Jonathan Clayden in organic chemistry. After 2 years, I joined Galapagos where I spent almost 11 years and became head of medicinal chemistry

  • Antonella Di Pizio: Computational Pharmacology of Taste and Olfactory Receptors | Dr. GPCR Ecosystem

    Trained as a medicinal chemist at the University of Chieti in Italy, she completed her PhD in computational medicinal chemistry before spending a formative period in Gerhard Klebe's structural biology lab in chemistry to bitter taste receptors 05:44 Trace amine-associated receptors on the edge of neuroscience So the research is more food-oriented and food-chemistry-oriented — this is why we have knowledge about Antonella trained as a medicinal chemist in Italy, followed by a Ph.D. in computational medicinal chemistry

  • Dr. Kenneth A. Jacobson | Dr. GPCR Ecosystem

    Jacobson received his BA in Liberal Arts from Reed College in 1976 and his Ph.D. in Chemistry from the currently the Senior Investigator and Chief of the Molecular Recognition Section, Laboratory of Bioorganic Chemistry His numerous awards include: 2008 Sato Award; 2009 Medicinal Chemistry Hall of Fame (American Chemical

View All
bottom of page